Zai Lab Limited announced the appointment of Josh Smiley as its Chief Operating Officer (COO). Mr. Smiley brings over 26 years of experience working within the biopharmaceutical industry, including experience leading finance, corporate strategy, business development, venture capital and the Global Business Services operations at Eli Lilly and Co (Lilly). Mr. Smiley will report directly to Dr. Du and will be a key member of Zai Lab's executive committee.

He will oversee all aspects of business, finance, and global operations. Mr. Smiley will be COO of Zai Lab beginning on August 1, 2022, following the completion of his leave with his current employer.